Financials
- Financial year
- 2024
- Total assets
- €3.8m
- Loss
- -€108,517
- Solvency
- 17.0%
Total assets▼ 1.1%
Net result
20182024
Patrimanne
ActiveSummary
The computed 12-month bankruptcy probability of Patrimanne is 6.2% (elevated). The 2024 annual accounts show equity of €649,749 and a net result of -€108,517. Equity is shrinking by about 8.4% per year across the filed financial years. Its solvency ranks better than 24% of 9,537 sector peers (NACE 47, financial year 2024). The company has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
5th largest company by total assets in Stekene, Wholesale and retail trade sector2 sites
Size
≈ €410,000turnover 2024, estimated
- Equity
- €649,749
- Loss
- -€108,517
Turnover estimated from the gross margin
Structure
2025 accounts not filed, 89 days past the deadline4 deeds in the Belgian Official Gazette
Why 35raises riskLiquidity: current ratio 0.52, cash €1,328, halved1 financial year not filed after the legal deadline; last filed accounts filed 333 days late; 3 of the last 3 lateFigures for financial year 2024 (filed 29-06-2026)lowers riskFounded in 2003Show the evidence
Checked score
Score 2024
35
/ 100
Weak
Probability in this band: 4.2% to 15.0%
Financially better than 28% of its sector peers (NACE 47, small)
Financial strength · tick = 2023
Weak
Solvency
42-3
equity 17.0% of total assets
Liquidity
44-1
short-term debt 20.1% · cash 0.0%
Profitability
17-3
return on assets -2.8%
Bankruptcy probability, 12 months
6.2%
Elevated
0%0.5%1.5%4%10%≥ 25%
About 6 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 3.0%
12-2024: 3.7%▲ +0.7 percentage points vs 11-2024
01-2025: 1.7%▼ -2.0 percentage points vs 12-2024lowest value
02-2025: 1.7%● unchanged vs 01-2025lowest value
03-2025: 2.0%▲ +0.3 percentage points vs 02-2025
04-2025: 2.0%● unchanged vs 03-2025
05-2025: 2.0%● unchanged vs 04-2025
06-2025: 2.1%▲ +0.1 percentage points vs 05-2025
07-2025: 2.1%● unchanged vs 06-2025
08-2025: 2.6%▲ +0.5 percentage points vs 07-2025
09-2025: 2.9%▲ +0.3 percentage points vs 08-2025
10-2025: 3.6%▲ +0.7 percentage points vs 09-2025
11-2025: 3.8%▲ +0.2 percentage points vs 10-2025
12-2025: 4.5%▲ +0.7 percentage points vs 11-2025
01-2026: 7.4%▲ +2.9 percentage points vs 12-2025
02-2026: 7.4%● unchanged vs 01-2026
03-2026: 7.5%▲ +0.1 percentage points vs 02-2026highest value
04-2026: 6.8%▼ -0.7 percentage points vs 03-2026
05-2026: 6.8%● unchanged vs 04-2026
06-2026: 6.8%● unchanged vs 05-2026
07-2026: 3.6%▼ -3.2 percentage points vs 06-2026
08-2026: 4.7%▲ +1.1 percentage points vs 07-2026
09-2026: 5.2%▲ +0.5 percentage points vs 08-2026
10-2026: 6.2%▲ +1.0 percentage point vs 09-2026
Credit of up to €22,000 on 30-day terms, only on tighter conditions: elevated estimated bankruptcy probability calls for adjusted credit terms
Liquidity insufficient (current ratio 0.52, compared with 0.51 in 2023, below 1; short-term debt: 20.1% and cash: 0% of total assets), and 83% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small): better than 31% on solvency, 51% on liquidity, 11% on profitability and 19% on growth.
The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Eight signals.
lowers riskraises risk
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024Net result per financial year
1819222324
2018 to 2024 · latest year -€108,517
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 9537 sector peers (2024).
NBB · sector comparisonPosition among 9537 sector peers
Solvency
better than 24%
← weakest
strongest →
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 89 days later.
NBB · 10 filingsPosition against the passed deadline
31-12-2025 year end31-07-2026 deadline28-10-2026 today
raises risk · 2024 accounts filed 333 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-06-2026, 333 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 10 filingsDeviation from the deadline
2025
not filed
2024
333 days late
2023
146 days late
2022
63 days late
2019
31 days late
2018
76 days late
2017
24 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 112 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (1)
- Annual accounts filedfinancial year 2024 · abbreviated…
- Annual accounts filedfinancial year 2023 · abbreviated…
- Weakest financial yearnet -€173,493
Key points
- Risk: 4 loss-making years in a rowloss financial year 2024 -€108,517 View
- Caution: Among the weakest 5% on net resultsector median €44,727 · 9,539 companies -€108,517 View
- Caution: 2025 accounts not fileddeadline was 31-07-2026 89 days past the deadline View
- Positive: Result rose in 2024from -€173,493 to -€108,517 ▲ 37.5% View
By topic
Timeline
- Events
- 23
- Since
- 2004
- 02-10-2023Annual accounts filed
- 31-12-2022Liquidity triples
- 31-08-2020Annual accounts filed
Company details
- Sites
- 2
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 10-02-2003
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Key facts about Patrimanne
- What is the company number of Patrimanne?
- 0479.459.518. In Belgium the VAT number is the company number with BE in front: BE 0479.459.518.
- Where is Patrimanne based?
- The registered office is at Dorpsstraat(STE) 29, 9190 Stekene.Company details
- What does Patrimanne do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Patrimanne?
- Private limited company (BV).
- When was Patrimanne founded?
- On 10-02-2003.
- Is Patrimanne still active?
- Yes, Patrimanne is an active enterprise in the KBO register.
- What is the turnover of Patrimanne?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is Patrimanne profitable?
- In financial year 2024, Patrimanne made a loss of €108,517.
- Where can I find the annual accounts of Patrimanne?
- Patrimanne filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
Companies related to Patrimanne
Comparable companies
- DE BRABANDERE C.Waregem
- DEPASSE - SCHONNE PHARMACIEEghezée
- APOTHEEK AERTS CAROLINEHerselt
- NATESSENCEEcaussinnes
- APOTHEEK CREMERSGistel
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.